Cardinal Health (CAH) director granted 1,702 RSUs; holdings 64,194
Cardinal Health (CAH) reported an insider equity award.
Rhea-AI Filing Summary
Cardinal Health (CAH) reported an insider equity award. A company director acquired 1,702 common shares on 11/05/2025 via an award priced at $0, reflecting a grant of restricted share units. Following the transaction, the director beneficially owns 64,194 shares directly.
The restricted share units are scheduled to vest on November 5, 2026, or on the date of the 2026 Annual Meeting of Shareholders if that meeting occurs before November 5, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 1,702 shares
Grant/Award
1 txn
Insider
KENNY GREGORY B
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Shares | 1,702 | $0.00 | $0.00 |
Holdings After Transaction:
Common Shares — 64,194 shares (Direct)
Footnotes (1)
- F1. Grant of restricted share units that will vest on November 5, 2026, except if the 2026 Annual Meeting of Shareholders is prior to November 5, 2026, then the restricted share units will vest on the date of the 2026 Annual Meeting of Shareholders.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did CAH disclose in this Form 4?
A director received an award of 1,702 restricted share units on 11/05/2025 at a price of $0.
What type of security was granted to the CAH director?
The filing notes a grant of restricted share units tied to 1,702 common shares.
Was there a purchase price for the CAH award?
No. The award is reported at a price of $0 as it reflects a grant of restricted share units.
What is the director’s relationship to CAH?
The reporting person is disclosed as a Director of Cardinal Health.
AI-generated analysis. How Rhea-AI works. Not financial advice.